PRP Clinical Trial
— TFCCOfficial title:
A Prospective Randomized Double Blinded Controlled Trial of Non-Operative Management of TFCC Injuries
Platelet-rich Plasma (PRP) is formed when a patient's blood sample is concentrated by a commercially available centrifuge. The sample then contains a high concentration of growth factors and has been used for numerous indications in a number of joints. This process has not yet been proven for non-operative management of the Triangular FibroCartilage Complex (TFCC), which is a very commonly injured soft tissue structure in the wrist. This study seeks to determine the efficacy of PRP for TFCC injuries.
Status | Recruiting |
Enrollment | 42 |
Est. completion date | December 31, 2022 |
Est. primary completion date | December 31, 2021 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | N/A and older |
Eligibility | Inclusion criteria: 1. Adult patients consenting for wrist injection, who additionally consent to participate in this study. 2. MRI which indicates a TFCC tear or Scapho-lunate ligament tear (SL) Exclusion criteria: 1. Patients who do not choose to participate in the study or who do not wish to have an injection 2. Patients who want an injection - but do not want to be randomized. 3. Patients who do not complete one of the follow up documentations. 4. Patients who would like to know their injection (unblinded) may be informed but the investigators will still attempt to collect data as per protocol. |
Country | Name | City | State |
---|---|---|---|
United States | Lola Norton | El Paso | Texas |
Lead Sponsor | Collaborator |
---|---|
William Beaumont Army Medical Center |
United States,
Dai WL, Zhou AG, Zhang H, Zhang J. Efficacy of Platelet-Rich Plasma in the Treatment of Knee Osteoarthritis: A Meta-analysis of Randomized Controlled Trials. Arthroscopy. 2017 Mar;33(3):659-670.e1. doi: 10.1016/j.arthro.2016.09.024. Epub 2016 Dec 22. Revi — View Citation
Gosens T, Peerbooms JC, van Laar W, den Oudsten BL. Ongoing positive effect of platelet-rich plasma versus corticosteroid injection in lateral epicondylitis: a double-blind randomized controlled trial with 2-year follow-up. Am J Sports Med. 2011 Jun;39(6) — View Citation
Heyworth BE, Lee JH, Kim PD, Lipton CB, Strauch RJ, Rosenwasser MP. Hylan versus corticosteroid versus placebo for treatment of basal joint arthritis: a prospective, randomized, double-blinded clinical trial. J Hand Surg Am. 2008 Jan;33(1):40-8. doi: 10.1 — View Citation
Hsu WK, Mishra A, Rodeo SR, Fu F, Terry MA, Randelli P, Canale ST, Kelly FB. Platelet-rich plasma in orthopaedic applications: evidence-based recommendations for treatment. J Am Acad Orthop Surg. 2013 Dec;21(12):739-48. doi: 10.5435/JAAOS-21-12-739. Revie — View Citation
Padilla S, Orive G, Sanchez M, Anitua E, Hsu WK. Platelet-rich plasma in orthopaedic applications: evidence-based recommendations for treatment. J Am Acad Orthop Surg. 2014 Aug;22(8):469-70. doi: 10.5435/JAAOS-22-08-469. — View Citation
Palmer AK, Werner FW. The triangular fibrocartilage complex of the wrist--anatomy and function. J Hand Surg Am. 1981 Mar;6(2):153-62. — View Citation
Peerbooms JC, Sluimer J, Bruijn DJ, Gosens T. Positive effect of an autologous platelet concentrate in lateral epicondylitis in a double-blind randomized controlled trial: platelet-rich plasma versus corticosteroid injection with a 1-year follow-up. Am J — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Disability of the Army Shoulder Hand (DASH) | SCALE: 0-100 (0 being a good result and 100 being complete disability) | Pre-injection | |
Primary | Disability of the Army Shoulder Hand (DASH) | SCALE: 0-100 (0 being a good result and 100 being complete disability) | 2 weeks post injection | |
Primary | Disability of the Army Shoulder Hand (DASH) | SCALE: 0-100 (0 being a good result and 100 being complete disability) | 3 months post injection | |
Primary | Disability of the Army Shoulder Hand (DASH) | SCALE: 0-100 (0 being a good result and 100 being complete disability) | 6 months post injection | |
Primary | Disability of the Army Shoulder Hand (DASH) | SCALE: 0-100 (0 being a good result and 100 being complete disability) | 12 months post injection | |
Secondary | Michigan Hand Outcome Questionnaire (MHOQ | SCALE: 0-100 (with 100 being a great result and 0 being considerable pain and dysfunction) | Pre-injection, 2 weeks, 3 months | |
Secondary | Mayo Wrist Score (Mayo) | SCALE: 0-100 (with 100 being a great result and 0 being considerable pain and dysfunction) | Pre-injection, 2 weeks, 3 months, 6 months, 12 months | |
Secondary | Pain Anxiety Symptom Scale (PASS) | SCALE: 0-100 (100 meaning a patient has a high level of anxiety, pain, apprehension; while a lower scale indicates a patient has no concerns or anxiety about pain. The average is about 38 and the standard deviation is 20) | Pre-injection, 2 weeks, 3 months | |
Secondary | Single Assessment Numerical Evaluation (SANE) | SCALE: 0-100 (with 100 being a great result and 0 being considerable pain and dysfunction) | Pre-injection, 2 weeks, 3 months, 6 months, 12 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05160441 -
Comparing Platelet Rich Plasma and Corticosteroid for Military & Civilian Patients With Glenohumeral Osteoarthritis
|
Phase 3 | |
Enrolling by invitation |
NCT05944757 -
Compare of PRP Autologous Serum and Autologous Serum by Intrastromal Injection in Different Eye Disease Conditions
|
N/A | |
Not yet recruiting |
NCT03633266 -
Anti-VEGF Instead of Intraoperative PRP in Proliferative Diabetic Retinopathy
|
N/A | |
Recruiting |
NCT04811287 -
PRP as Adjuvant Treatment to CTR for Severe CTS Tunnel Syndrome
|
N/A | |
Recruiting |
NCT04586361 -
Prospective Analysis of Introperative RegenLab PRP and Hyaluronic Acid in Patients With Knee ACL Tear
|
Phase 4 | |
Completed |
NCT05827484 -
The Effect of Combined Use of Anti-fibrotic Agent With Platelet Rich Plasma on Skeletal Muscle Healing After Acute Injuries
|
Phase 4 | |
Active, not recruiting |
NCT04556825 -
Arthroscopic Treatment Combined With PRP Injection for Refractory Elbow Epicondylitis
|
N/A | |
Recruiting |
NCT04765930 -
Combined Q-switched Nd:YAG Laser and Platelet Rich Plasma Versus Q- Switched Nd:YAG Laser Alone in Melasma
|
N/A | |
Terminated |
NCT03937765 -
The Effect of Platelet Rich Plasma on Pain at Skin Graft Donor Sites
|
N/A | |
Recruiting |
NCT05241964 -
Platelet-rich Plasma(PRP) Injection in ED
|
N/A | |
Recruiting |
NCT05279560 -
Ovarian PRP (Platelet Rich Plasma) Injection for Follicular Activation
|
N/A | |
Not yet recruiting |
NCT06298110 -
The Effect of PRP on Wound Healing in High Risk Patients Undergoing Abdominal Hysterectomy
|
Phase 2/Phase 3 | |
Recruiting |
NCT06028009 -
PRP Injections for Genitourinary Syndrome of Menopause
|
N/A | |
Completed |
NCT04976361 -
Macular Vessels Density Before and After PRP in Patients With Proliferative Diabetic Retinopathy
|
N/A | |
Recruiting |
NCT05412381 -
PRP in ACLR to Prevent PTOA
|
Phase 4 | |
Recruiting |
NCT03987256 -
ECRB Tendinopathy: Needling ± PRP After Failure of Rehabilitation
|
N/A | |
Completed |
NCT04320498 -
Short Term Results of Platelet-rich Plasma in the Treatment of Chronic Anal Fissure
|
Phase 4 | |
Completed |
NCT04640662 -
The Effects of Platelet-Rich Plasma Versus Prolotherapy On Rotator Cuff Tendinopathy: A Randomized Controlled Trial.
|
Phase 1 | |
Completed |
NCT03371888 -
The Platelet-Rich Plasma in the Therapy of Temporomandibular Disorders
|
Phase 2/Phase 3 | |
Recruiting |
NCT04519047 -
IA Injection of Rejoint Gel and PRP in Patients With Unilateral Knee OA
|
Phase 1 |